Envista Holdings Corp (NVST) - Net Assets
Based on the latest financial reports, Envista Holdings Corp (NVST) has net assets worth $3.09 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.64 Billion) and total liabilities ($2.55 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Envista Holdings Corp (NVST) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.09 Billion |
| % of Total Assets | 54.73% |
| Annual Growth Rate | -7.31% |
| 5-Year Change | -21.13% |
| 10-Year Change | N/A |
| Growth Volatility | 14.45 |
Envista Holdings Corp - Net Assets Trend (2017–2024)
This chart illustrates how Envista Holdings Corp's net assets have evolved over time, based on quarterly financial data. Also explore Envista Holdings Corp assets under control for the complete picture of this company's asset base.
Annual Net Assets for Envista Holdings Corp (2017–2024)
The table below shows the annual net assets of Envista Holdings Corp from 2017 to 2024. For live valuation and market cap data, see NVST market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $2.93 Billion | -29.69% |
| 2023-12-31 | $4.17 Billion | -0.78% |
| 2022-12-31 | $4.21 Billion | +3.67% |
| 2021-12-31 | $4.06 Billion | +9.06% |
| 2020-12-31 | $3.72 Billion | +5.03% |
| 2019-12-31 | $3.54 Billion | -26.60% |
| 2018-12-31 | $4.83 Billion | -3.37% |
| 2017-12-31 | $4.99 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Envista Holdings Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 48740000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.70 Million | 0.06% |
| Other Comprehensive Income | $-371.10 Million | -12.64% |
| Other Components | $3.79 Billion | 129.19% |
| Total Equity | $2.93 Billion | 100.00% |
Envista Holdings Corp Competitors by Market Cap
The table below lists competitors of Envista Holdings Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dana Inc
NYSE:DAN
|
$3.93 Billion |
|
Hilton Grand Vacations Inc
NYSE:HGV
|
$3.93 Billion |
|
Munters Group AB
ST:MTRS
|
$3.93 Billion |
|
Bath & Body Works Inc.
NYSE:BBWI
|
$3.93 Billion |
|
Nordic Semiconductor ASA
OL:NOD
|
$3.93 Billion |
|
Dropbox Inc
NASDAQ:DBX
|
$3.92 Billion |
|
Vallourec
PA:VK
|
$3.92 Billion |
|
DKSH Holding AG
SW:DKSH
|
$3.92 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Envista Holdings Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,173,900,000 to 2,934,800,000, a change of -1,239,100,000 (-29.7%).
- Net loss of 1,118,600,000 reduced equity.
- Other comprehensive income decreased equity by 153,900,000.
- Other factors increased equity by 33,400,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.12 Billion | -38.12% |
| Other Comprehensive Income | $-153.90 Million | -5.24% |
| Other Changes | $33.40 Million | +1.14% |
| Total Change | $- | -29.69% |
Book Value vs Market Value Analysis
This analysis compares Envista Holdings Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.54x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.82x to 1.54x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $32.28 | $26.33 | x |
| 2018-12-31 | $31.20 | $26.33 | x |
| 2019-12-31 | $25.95 | $26.33 | x |
| 2020-12-31 | $22.67 | $26.33 | x |
| 2021-12-31 | $22.85 | $26.33 | x |
| 2022-12-31 | $23.69 | $26.33 | x |
| 2023-12-31 | $25.01 | $26.33 | x |
| 2024-12-31 | $17.04 | $26.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Envista Holdings Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -38.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -44.56%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.82x
- Recent ROE (-38.12%) is below the historical average (-1.06%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 6.03% | 10.71% | 0.47x | 1.20x | $-197.95 Million |
| 2018 | 4.78% | 8.11% | 0.49x | 1.21x | $-251.61 Million |
| 2019 | 6.15% | 9.52% | 0.37x | 1.74x | $-136.42 Million |
| 2020 | 0.90% | 1.73% | 0.28x | 1.85x | $-338.76 Million |
| 2021 | 8.39% | 13.57% | 0.38x | 1.62x | $-65.26 Million |
| 2022 | 5.78% | 9.46% | 0.39x | 1.57x | $-177.59 Million |
| 2023 | -2.40% | -3.90% | 0.39x | 1.58x | $-517.59 Million |
| 2024 | -38.12% | -44.56% | 0.47x | 1.82x | $-1.41 Billion |
Industry Comparison
This section compares Envista Holdings Corp's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $870,414,600
- Average return on equity (ROE) among peers: -28.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Envista Holdings Corp (NVST) | $3.09 Billion | 6.03% | 0.83x | $3.93 Billion |
| Akoya Biosciences Inc (AKYA) | $18.57 Million | -89.96% | 3.18x | $64.44 Million |
| Align Technology Inc (ALGN) | $99.40 Million | -98.06% | 0.19x | $12.66 Billion |
| AngioDynamics Inc (ANGO) | $424.49 Million | -6.25% | 0.30x | $444.32 Million |
| AptarGroup Inc (ATR) | $1.28 Billion | 13.56% | 0.59x | $7.66 Billion |
| AtriCure Inc (ATRC) | $483.76 Million | 10.38% | 0.27x | $1.44 Billion |
| Avinger Inc (AVGR) | $-143.87 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $62.68 Million | -121.71% | 0.29x | $156.14 Million |
| Avantor Inc (AVTR) | $-3.05 Billion | 0.00% | 0.00x | $5.43 Billion |
| Azenta Inc (AZTA) | $415.04 Million | 3.07% | 0.24x | $1.04 Billion |
| Baxter International Inc (BAX) | $9.12 Billion | 6.60% | 0.88x | $8.85 Billion |
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabr… Read more